Obagi Medical Products Inc

Type: Company
Name: Obagi Medical Products Inc
Nationality: United States
Web Address: http://www.obagi.com/
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Atlanta Plastic Surgery Center Now Offering Discount on Skincare and Sunscreen Products

Perimeter Plastic Surgery is offering a discount on all Obagi Medical skincare products including sunscreen to help patients prepare and protect their skin for the summer months. Perimeter Plastic Surgery, an Atlanta plastic surgery center, is currently ... [Published PRWeb - Apr 08 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Zein Obagi, MD, To Introduce New ZO(r) Skin Health Systems And Protocols At The

Aesthetic Meeting 201404/07 05:17 CDT Aesthetic Meeting 2014 IRVINE, Calif., April 7, 2014IRVINE, Calif., April 7, 2014 /PRNewswire/ -- Renowned dermatologist Zein Obagi, MD, Founder and Medical Director of ZO Skin Health, Inc., announces the launch ... [Published Finwin - Apr 07 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Rachael Eckel, M.D. To Present ZO® Skin Health Seminar At AMWC In Monaco

IRVINE, Calif.Based on the AMWC's unique hallmark, the congress program is planned around effective aging prevention and treatment by comprehensively addressing aesthetics strategy (dermatology and surgery) for the external appearance and applying anti-aging ... [Published PR Newswire - Mar 24 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Valeant's CEO, a crackerjack cost-cutter, seeks more 'fat' companies to buy

Back in January, Valeant Pharmaceuticals' CEO J. Michael Pearson couldn't say how he intended to reach his lofty goal of cracking the list of top 5 drugmakers worldwide. Now, he's offering new details about his acquisition blueprints, and they include ... [Published FiercePharma - Mar 20 2014]
First reported Mar 17 2014 - Updated Mar 18 2014 - 1 reports

Maverick Capital buys a position in Valeant Pharmaceuticals

Lee Ainslie and Maverick Capital's 4Q13 positions (Part 3 of 7)( Continued from Part 2 )Maverick Capital and Valeant PharmaceuticalsLee Ainslie’s Maverick Capital initiated positions in eBay (EBAY), Valeant Pharmaceuticals International, Inc. (VRX), Catamaran ... [Published Yahoo! Finance - Mar 17 2014]
First reported Mar 10 2014 - Updated Mar 10 2014 - 1 reports

ZO Skin Health, Inc. Announces 2014 Educational Programs Presented By Dr. Obagi

/PRNewswire/ -- ZO Skin Health, Inc. is pleased to announce that internationally-renowned dermatologist Zein Obagi, M.D., will host educational seminars and webinars throughout the year to educate physicians, skincare professionals and consumers on the ... [Published 4 Traders - Mar 10 2014]
First reported Feb 07 2014 - Updated Feb 07 2014 - 1 reports

Can Novel-Novel Combinations Work? Deals Of The Week Watches Merck Test The Waters

Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ... [Published The IN VIVO Blog - Feb 07 2014]
First reported Feb 03 2014 - Updated Feb 03 2014 - 1 reports

Monday Deal Review: February 3, 2014

  Welcome to your Monday Biotech Deal Review for February 03, 2014! This week saw Jamieson Labs complete the sale of their business to CCMP Capital Advisors, LLC. In the commercial space, Sirona has executed licensing agreements with Obagi Medical ... [Published The Cross-Border Biotech Blog - Feb 03 2014]
First reported Jan 29 2014 - Updated Jan 29 2014 - 2 reports

Sirona Biochem licenses TFC-849 to Obagi Medical

Sirona Biochem Corp. has formally executed the global exclusive licensing agreement with Obagi Medical Products for the commercialization of skin lightening compound TFC-849. Sirona Biochem will receive a licensing fee and royalty payments for global ... [Published Stockwatch - Jan 29 2014]
First reported Jan 14 2014 - Updated Jan 14 2014 - 1 reports

Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally

Histogen today announced that they have entered into an international license agreement with Suneva Medical for aesthetic products containing Histogen’s proprietary multipotent cell conditioned media (CCM). Histogen, Inc., a regenerative medicine company ... [Published PRWeb - Jan 14 2014]
First reported Nov 13 2013 - Updated Nov 13 2013 - 1 reports

Multipotent Stem Cell Proteins Support Soft Tissue Regeneration

Histogen to present data at TERMIS AM Annual Conference in Atlanta. Brackets indicate dermal/epidermal thickness (au) Histogen, Inc., a regenerative medicine company developing solutions based on the products of cells grown under simulated embryonic conditions, ... [Published PRWeb - Nov 13 2013]

Quotes

Dr. Obagi says, "I will cover how to identify when to choose chemical peels and when to choose CO2 fractional lasers in skin resurfacing based on skin type, skin thickness, and treatment objectives. I will also discuss how to define a safe depth for skin resurfacing procedures and how to evaluate and handle certain complications including pigmentary changes, scars, and keloids."
As Bloomberg reports, Valeant ($VRX) is scouting for pickups in the three specialty fields, all of which "are growing faster than the overall growth rate of health care" Pearson told the news service Wednesday...
...Obagi's latest discoveries through ZO® Skin Health's suite of educational programs," said Jim Headley, CEO and President of ZO Skin Health, Inc. "We are committed to partnering with our physician community, and collaborating to develop products and protocols that drive the aesthetic industry further into the future."
...” In addition to "Human Multipotent Stem Cell Proteins Support Soft Tissue Regeneration,” Dr. Zimber will also be presenting “Human Multipotent Stem Cell Proteins Support Osteogenesis In Vitro” during the TERMIS AM Annual Meeting taking place November 10-13, 2013 in Atlanta. Following the event, these presentations will be available upon request."

More Content

All (16) | News (12) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Atlanta Plastic Surgery Center Now Offering Dis... [Published PRWeb - Apr 08 2014]
Zein Obagi, MD, To Introduce New ZO(r) Skin Hea... [Published Finwin - Apr 07 2014]
Rachael Eckel, M.D. To Present ZO® Skin Health ... [Published PR Newswire - Mar 24 2014]
Valeant's CEO, a crackerjack cost-cutter, seeks... [Published FiercePharma - Mar 20 2014]
Maverick Capital buys a position in Valeant Pha... [Published Yahoo! Finance - Mar 17 2014]
ZO Skin Health, Inc. Announces 2014 Educational... [Published 4 Traders - Mar 10 2014]
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
OBAGI 360 HYDRAFACTOR MOISTURIZING BROAD SPECTR... [Published DailyMed Drug Label Updates for the last seven ... - Feb 04 2014]
Monday Deal Review: February 3, 2014 [Published The Cross-Border Biotech Blog - Feb 03 2014]
Sirona Biochem licenses TFC-849 to Obagi Medical [Published Stockwatch - Jan 29 2014]
Sirona Biochem Completes Global Exclusive Licen... [Published Marketwire - Breaking News Releases - Jan 29 2014]
Histogen and Suneva Medical Expand License for ... [Published PRWeb - Jan 14 2014]
Multipotent Stem Cell Proteins Support Soft Tis... [Published PRWeb - Nov 13 2013]
Histogen to Present at 2013 Stem Cell Meeting o... [Published PRWeb - Oct 11 2013]
Histogen’s Method of Generating Multipotent Ste... [Published PRWeb - Sep 03 2013]
ZO Skin Health to host ZO Skin Health education... [Published PharmaBiz - Jul 20 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ...
OBAGI 360 HYDRAFACTOR MOISTURIZING BROAD SPECTR... [Published DailyMed Drug Label Updates for the last seven ... - Feb 04 2014]
Updated Date: Feb 4, 2014 EST ...
Monday Deal Review: February 3, 2014 [Published The Cross-Border Biotech Blog - Feb 03 2014]
  Welcome to your Monday Biotech Deal Review for February 03, 2014! This week saw Jamieson Labs complete the sale of their business to CCMP Capital Advisors, LLC. In the commercial space, Sirona has executed licensing agreements with Obagi Medical ...
Sirona Biochem Completes Global Exclusive Licen... [Published Marketwire - Breaking News Releases - Jan 29 2014]
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 29, 2014) - Sirona Biochem Corp . (TSX VENTURE:SBM)(OTCQX:SRBCF)(FRANKFURT:ZSB) announced today the formal execution of the global exclusive licensing agreement with Obagi Medical Products (Obagi) for ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.